Clinical Trial Update: Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease

View source ↗

Summary

A completed observational study assessing long-term immunogenicity and potential efficacy of the UB-311 vaccine in individuals with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• UB-311 vaccine (UB-311)

Snippet

Sponsor: United Biomedical | Conditions: Alzheimer's Disease | Status: COMPLETED